Ibisobanuro
Methyl 2-cyanoisonicotinate nisuku ryinshi, ryuzuye ryujuje ibyangombwa bisabwa kugirango synthesis.Ubwiza bwayo buhebuje kandi buhoraho bituma igira uruhare rukomeye mu masosiyete yimiti n’ibigo by’ubushakashatsi bikora ku iterambere n’umusaruro wa topirastat.
Uru ruganda rwagati nurufunguzo rwo gutangira ibintu muri synthesis ya topirastat.Ikora neza yitonze yimiti yimiti itanga umusaruro wanyuma wa farumasi.Kubwibyo, isuku, ituze, hamwe nubwizerwe bwa methyl 2-cyanoisonicotinate nibyingenzi kugirango hamenyekane ubuziranenge nubushobozi bwibicuruzwa byanyuma.
Methyl 2-cyanoisonicotinate ikorwa hifashishijwe inzira zigezweho nibikoresho bigezweho kugirango tumenye neza nubuziranenge.Ikora igeragezwa nisesengura rikomeye kugirango irebe ko yujuje ubuziranenge bwo hejuru bwashyizweho ninganda zimiti.Nkigisubizo, abakiriya bacu barashobora kwigirira ikizere mubwizerwa no guhuzagurika kwuru ruganda rwingenzi.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ry'umwuga ryizeza R&D y'ibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
